Evaluation and comparison of human absorbed dose of 90 Y-DOTA-Cetuximab in various age groups based on distribution data in rats
Open Access
- 1 January 2012
- journal article
- research article
- Published by Medknow in Journal of Medical Physics
- Vol. 37 (4) , 226-234
Abstract
The organ radiation-absorbed doses have been evaluated for humans in six age groups and both genders based on animal data. After intravenous administration of 90 Y-DOTA-Cetuximab to five groups of rats, they were sacrificed at exact time intervals (2, 24, 48, 72, and 96 h) and the percentage of injected dose per gram of each organ was calculated by direct counting from rat data. By using the formulation that Medical Internal Radiation Dose suggests, radiation-absorbed doses for all organs were calculated and extrapolated from rat to human. The total body absorbed dose for all groups was >22 mGy due to pure β-emission of the applied radiopharmaceutical. The effective dose resulting from an intravenously injected activity of 100 MBq is 56.7 mSv for a 60-kg female adult and 60.3 mSv for a 73-kg male adult. The results demonstrated the usefulness of this method for estimation of β-absorbed dose in humans.Keywords
This publication has 24 references indexed in Scilit:
- Cetuximab-Based Immunotherapy and Radioimmunotherapy of Head and Neck Squamous Cell CarcinomaClinical Cancer Research, 2010
- Determination of human absorbed dose of 67GA-DTPA-ACTH based on distribution data in ratsRadiation Protection Dosimetry, 2009
- MIRD Dose Estimate Report No. 20: Radiation Absorbed-Dose Estimates for 111In- and 90Y-Ibritumomab TiuxetanJournal of Nuclear Medicine, 2009
- Disparity Between In Vivo EGFR Expression and 89Zr-Labeled Cetuximab Uptake Assessed with PETJournal of Nuclear Medicine, 2008
- Cetuximab: Preclinical Evaluation of a Monoclonal Antibody Targeting EGFR for Radioimmunodiagnostic and Radioimmunotherapeutic ApplicationsCancer Biotherapy and Radiopharmaceuticals, 2008
- High-Dose Radioimmunotherapy with 90Y-Ibritumomab Tiuxetan: Comparative Dosimetric Study for Tailored TreatmentJournal of Nuclear Medicine, 2007
- A two-tiered physiologically based model for dually labeled single-chain Fv-Fc antibody fragmentsMolecular Cancer Therapeutics, 2006
- New Issues on Cetuximab Mechanism of Action in Epidermal Growth Factor Receptor–Negative Colorectal Cancer: The Role of Vascular Endothelial Growth FactorJournal of Clinical Oncology, 2006
- Biodistribution and Dosimetry of 177 Lu-Labeled [DOTA 0 ,Tyr 3 ]Octreotate in Male Nude Mice with Human Small Cell Lung CancerCancer Biotherapy and Radiopharmaceuticals, 2003
- Estimation of Radiation Absorbed Doses to the Red Marrow in RadioimmunotherapyClinical Nuclear Medicine, 1995